In this single-centre , randomised , double-blind , placebo-controlled trial , adult patients ( aged @ years and older ) with obstructive or non-obstructive hypertrophic cardiomyopathy were randomly assigned via computer-based system to losartan ( @ mg per day ) or placebo for @ months .